Patrick William Tuer
Known title: EVP, Chief Operating OfficerCIK: 0002065822
Associated companies
Transaction History
| EHC | ▼ Sell | Open Market | 682 | $71K | 5/11/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 545 | $59K | 2/28/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 506 | $54K | 2/23/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 405 | $43K | 2/20/2026 | View on chart |
| EHC | ▲ Buy | Grant | 3,790 | $0 | 2/19/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 3,193 | $342K | 2/19/2026 | View on chart |
| EHC | ▲ Buy | Grant | 10,254 | $0 | 2/18/2026 | View on chart |
| EHC | ▼ Sell | Open Market | 2,804 | $302K | 2/10/2026 | View on chart |
| EHC | ▼ Sell | Open Market | 1,020 | $126K | 8/27/2025 | View on chart |
| EHC | ▲ Buy | Grant | 5,984 | $0 | 4/30/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.